ATLANTIC BEACH, Fla.--(BUSINESS WIRE)--Sep 8, 2026--
nPhase, Inc., the clinical research technology company known for REDCap Cloud, today launched nPhase.ai, the life sciences industry’s first enterprise platform for end-to-end clinical data management. The company also introduces nPhase.ai SCE (Statistical Computing Environment). An AI-native platform built on Clinical Data Interchange Standards Consortium (CDISC) standards, the governed platform transforms raw clinical trial data into submission-ready outputs at least 4x faster with 80% fewer resources.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908866634/en/
Clinical trial data has outgrown existing systems both in volume and complexity. A recent Tufts CSDD analysis found the average phase III protocol now generates nearly six million data points. Most of that volume arrives from unstructured data systems that were never designed to interoperate, leaving sponsors with data that is difficult to reuse or be leveraged by AI.
“Clinical data has never been more complex, with information flowing from dozens of systems, with different formats, structures, and types,” said Scott Climes, CEO of nPhase, Inc. “nPhase.ai addresses this pervasive challenge by transforming disparate clinical data into high-fidelity, harmonized datasets in near real-time, enabling faster analytics, better insights, and more informed decision-making. Now, with SCE, we are combining the speed and intelligence of AI with human oversight to make clinical data truly AI-ready from source to submission.”
nPhase.ai SCE automatically converts raw study data into the regulatory artifacts required for submission through one, governed, and traceable pipeline. It compresses a process that typically takes four or more months to weeks. Every week gained between last-patient-last-visit and submission not only accelerates treatments to patients but also gives sponsors additional market exclusivity.
nPhase.ai SCE provides the following key benefits:
“CDISC standards exist to make clinical data usable across systems and sponsors," said Chris Decker, President and CEO of CDISC. "CDISC’s transformation to Machine-readable standards is the foundation that makes automation of clinical data workflows possible. We're glad to see the industry building tools that rely on that foundation.”
Visit nPhase at SCDM 2026, Sept. 14–17, Raleigh, N.C. (booth 525), and DPHARM, Sept. 15–16, Boston (booth 407). Or sign up for a personal demohere.
About nPhase, Inc.
nPhase, Inc. builds clinical research technology that connects clinical trial and real-world data into a single foundation for clinical decision making. Its enterprise platform, nPhase.ai enables the application of AI at every stage of the clinical data layer, from acquisition through submission, for pharmaceutical sponsors and CROs. Its first products include nPhase.ai SCE and a unified data management system (UDMS). REDCap Cloud EDC serves small and mid-size sponsors, non-profit and academic research organizations, MedTech studies and real-world data programs. More at www.nphase.ai and www.redcapcloud.com.
End-to-End Clinical Research
LONDON (AP) — Britain is set to ban goods from Israeli settlements in the occupied West Bank in response to an expansion program that is imperiling efforts to establish a Palestinian state, the U.K. government said Tuesday.
Foreign Secretary Ed Miliband is due to give details in the House of Commons later, after saying last week that he would “reset” U.K. relations with Israel.
It's a significant toughening of Britain’s stance towards Israel, whose conduct towards the Palestinians under Prime Minister Benjamin Netanyahu has increasingly been criticized by the U.K. and other Israeli allies. Under Netanyahu's ultranationalist government, settlement construction in the West Bank has surged.
The international community overwhelmingly considers such construction to be illegal and an obstacle to peace.
Before the announcement, Work and Pensions Secretary Pat McFadden said that it “isn’t intended to be a boycott of all Israeli goods.”
He said that the measures were “specifically targeted at the expansion of these settlements, which are illegal under international law, in the West Bank.”
“At the heart of the statement is the idea that the U.K., along with many other countries, do not want to see the possibility of a two-state solution in Israel and Palestine being erased by changes to the facts on the ground,” McFadden told Times Radio.
The United Kingdom, a longtime ally of Israel, recognized Palestinian statehood last year in an attempt to revive dwindling efforts to achieve a two-state solution.
The center-left Labour Party government has previously sanctioned some Israeli settlers and illegal outposts over violence against Palestinians and illegal development in the West Bank. Tuesday's announcement is set to expand sanctions to cover trade in goods, and possibly some services, with all West Bank settlements.
U.K. Prime Minister Andy Burnham has voiced concerns about the E1 settlement project approved by Israel, which would effectively cut the territory in two. Palestinians and rights groups say it could destroy hopes for a future Palestinian state.
A tougher line on settlements is likely to be welcomed by many Labour voters and lawmakers, who have urged the government to go further in sanctioning Israel and supporting the Palestinians.
But some Labour members expressed concern that the move could boost support for Netanyahu, who is facing a tough battle for reelection in October, or lead to attacks on British Jews.
Israeli President Isaac Herzog said the ban would be “a grave miscalculation, a decision that will fall on the wrong side of history.
“In the current context, it would be a gross interference in the democratic elections of a sovereign nation,” he said.
Senior Israeli ministers condemned the U.K. government’s impending announcement. Foreign Minister Gideon Saar warned that “if Britain acts against Israel, Israel will act against Britain.”
Itamar Ben-Gvir, Israel’s hard-line public security minister, called on Netanyahu to recognize Argentina’s claim to the Falkland Islands, a British overseas territory in the South Atlantic known in Argentina as Islas Malvinas.
The move was also criticized by the U.S. ambassador to Israel, Mike Huckabee, who said that it was “discrimination against the Jewish people.” He said that the U.K. could face “repercussions or retaliations” from the U.S. if it imposed the sanctions.
Several U.S. states have laws banning contracts or investments with businesses that boycott Israeli firms, including those based in the West Bank. U.S. Rep. Randy Fines, R-Fla., said in a post on social media that the U.K. ban could put at risk “billions of dollars” in trade between British businesses and Florida.
Burnham’s office said that the prime minister spoke to U.S. President Donald Trump on Monday and set out “the U.K.’s commitment to working toward peace and security in the region” and achieving a two-state solution. There was no word on how Trump responded.
Israel seized the West Bank in the 1967 Mideast war and which would make up the main part of a future Palestinian state.
Netanyahu’s government views the West Bank as the biblical and historical homeland of the Jewish people and is opposed to the creation of a Palestinian state
—-
Megan Mineiro contributed to this report from Jerusalem.
FILE - Britain's Foreign Secretary Ed Miliband speaks during a press conference in Madrid, Spain, on July 29, 2026. (Leon Neal/Pool Photo via AP, File)
